In a new mouse study, Salk researchers found a drug, CMS121, that appears to treat neurodegeneration in mice. Researchers at the Salk Institute for…
Phase III trials for experimental dementia-related psychosis treatment pimavanserin draw interest at AAIC; FDA begins consideration of the drug approval. As many as half…
Alzheimer’s clinical trials may take decades, but a new discovery could cut clinical trial time down to a matter of weeks. For nearly a century,…
Scientists at UCSF have discovered an exercise enzyme. Exercise is one of the most well-studied and most powerful ways of protecting the brain from…
In another step toward what could be the first treatment for early stage Alzheimer’s, Biogen and Eisai today said they have completed an application…
A new study reveals that the asthma drug salbutamol may offer potential as a treatment for Alzheimer’s disease. Alzheimer’s Disease takes hundreds of thousands…
For decades, research has been conducted on the potential of transplanting healthy cells into unhealthy brains as a means of improvement. A recent article…
Follow us